Evolent Health, Inc.
EVH
$4.20
$0.000.00%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -16.65% | -6.71% | 10.24% | 30.09% | 37.65% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -16.65% | -6.71% | 10.24% | 30.09% | 37.65% |
| Cost of Revenue | -19.09% | -4.18% | 17.62% | 45.49% | 53.59% |
| Gross Profit | -3.80% | -17.79% | -18.25% | -20.22% | -11.01% |
| SG&A Expenses | 11.95% | -2.41% | -12.32% | -17.51% | -23.53% |
| Depreciation & Amortization | -15.64% | -12.51% | -8.67% | -4.09% | 4.47% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.80% | -4.42% | 12.04% | 32.54% | 36.62% |
| Operating Income | -84.74% | -117.53% | -105.32% | -93.83% | 247.94% |
| Income Before Tax | -46.54% | -39.50% | 16.40% | 68.86% | 47.02% |
| Income Tax Expenses | 102.88% | 94.49% | 97.54% | 98.42% | 79.69% |
| Earnings from Continuing Operations | -77.46% | -75.30% | 1.25% | 45.49% | 20.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -77.46% | -75.30% | 1.25% | 45.49% | 20.60% |
| EBIT | -84.74% | -117.53% | -105.32% | -93.83% | 247.94% |
| EBITDA | 1.38% | -18.10% | -1.12% | 3.00% | 29.73% |
| EPS Basic | -71.92% | -71.39% | 2.63% | 36.14% | 10.93% |
| Normalized Basic EPS | -1,274.69% | -578.07% | -2,846.05% | 73.81% | 106.74% |
| EPS Diluted | -71.92% | -71.39% | 2.63% | 36.14% | 10.94% |
| Normalized Diluted EPS | -1,274.69% | -578.07% | -2,846.05% | 73.81% | 106.74% |
| Average Basic Shares Outstanding | 0.66% | 1.41% | 1.91% | 3.10% | 6.06% |
| Average Diluted Shares Outstanding | 0.66% | 1.41% | 1.91% | 3.10% | 6.06% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.56% | 0.46% | 0.02% | -0.96% | -0.89% |